| Alexander Turchin, MD | |
|
221 Longwood Avenue, Rfb 2, Boston, MA 02115 | |
| (617) 732-5661 | |
| Not Available |
| Full Name | Alexander Turchin |
|---|---|
| Gender | Male |
| Speciality | Endocrinology |
| Experience | 25 Years |
| Location | 221 Longwood Avenue, Boston, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790735207 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 209682 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Brigham And Women's Hospital | Boston, MA | Hospital |
| Faulkner Hospital-brigham And Women's | Boston, MA | Hospital |
| North Shore Medical Center - | Salem, MA | Hospital |
| Newton-wellesley Hospital | Newton, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Massachusetts General Physicians Organization Inc | 2466365820 | 3085 |
| Brigham And Women's Physicians Organization Inc | 3870405988 | 2510 |
News Archive
The novel angiotensin receptor neprilysin inhibitor, LCZ696, demonstrated beneficial effects in heart failure patients with preserved ejection fraction (HFpEF), according to results of the PARAMOUNT (Prospective compArison of ARNI with ARB on Management Of heart failUre with preserved ejectioN fracTion) trial.
Aegis Health Group will help Inova Health System, a not-for-profit healthcare system based in northern Virginia, grow market share through its proven business development strategies. Using Aegis' program Inova's seven hospitals will begin working with local employers to better manage the health of their workforce and link hospital-sponsored programs and services with the specific health-related needs of local businesses.
A blood test yields a wealth of information crucial to a person's health. What's needed is a device that is small and inexpensive, yet capable of quickly providing a thorough analysis using a very small sample.
Drugs designed to halt cancer growth may offer a new way to control high blood pressure (hypertension), say Georgetown University Medical Center investigators.
In-hospital mortality rates for patients who have atrial fibrillation are significantly higher on the weekend than on weekdays, show US study results.
› Verified 7 days ago
| Entity Name | Massachusetts General Physicians Organization Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801874573 PECOS PAC ID: 2466365820 Enrollment ID: O20031111000434 |
News Archive
The novel angiotensin receptor neprilysin inhibitor, LCZ696, demonstrated beneficial effects in heart failure patients with preserved ejection fraction (HFpEF), according to results of the PARAMOUNT (Prospective compArison of ARNI with ARB on Management Of heart failUre with preserved ejectioN fracTion) trial.
Aegis Health Group will help Inova Health System, a not-for-profit healthcare system based in northern Virginia, grow market share through its proven business development strategies. Using Aegis' program Inova's seven hospitals will begin working with local employers to better manage the health of their workforce and link hospital-sponsored programs and services with the specific health-related needs of local businesses.
A blood test yields a wealth of information crucial to a person's health. What's needed is a device that is small and inexpensive, yet capable of quickly providing a thorough analysis using a very small sample.
Drugs designed to halt cancer growth may offer a new way to control high blood pressure (hypertension), say Georgetown University Medical Center investigators.
In-hospital mortality rates for patients who have atrial fibrillation are significantly higher on the weekend than on weekdays, show US study results.
› Verified 7 days ago
| Entity Name | The General Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023049236 PECOS PAC ID: 6507803806 Enrollment ID: O20080313000351 |
News Archive
The novel angiotensin receptor neprilysin inhibitor, LCZ696, demonstrated beneficial effects in heart failure patients with preserved ejection fraction (HFpEF), according to results of the PARAMOUNT (Prospective compArison of ARNI with ARB on Management Of heart failUre with preserved ejectioN fracTion) trial.
Aegis Health Group will help Inova Health System, a not-for-profit healthcare system based in northern Virginia, grow market share through its proven business development strategies. Using Aegis' program Inova's seven hospitals will begin working with local employers to better manage the health of their workforce and link hospital-sponsored programs and services with the specific health-related needs of local businesses.
A blood test yields a wealth of information crucial to a person's health. What's needed is a device that is small and inexpensive, yet capable of quickly providing a thorough analysis using a very small sample.
Drugs designed to halt cancer growth may offer a new way to control high blood pressure (hypertension), say Georgetown University Medical Center investigators.
In-hospital mortality rates for patients who have atrial fibrillation are significantly higher on the weekend than on weekdays, show US study results.
› Verified 7 days ago
| Entity Name | Sound Physicians Of Massachusetts Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740678408 PECOS PAC ID: 2062554637 Enrollment ID: O20100120000133 |
News Archive
The novel angiotensin receptor neprilysin inhibitor, LCZ696, demonstrated beneficial effects in heart failure patients with preserved ejection fraction (HFpEF), according to results of the PARAMOUNT (Prospective compArison of ARNI with ARB on Management Of heart failUre with preserved ejectioN fracTion) trial.
Aegis Health Group will help Inova Health System, a not-for-profit healthcare system based in northern Virginia, grow market share through its proven business development strategies. Using Aegis' program Inova's seven hospitals will begin working with local employers to better manage the health of their workforce and link hospital-sponsored programs and services with the specific health-related needs of local businesses.
A blood test yields a wealth of information crucial to a person's health. What's needed is a device that is small and inexpensive, yet capable of quickly providing a thorough analysis using a very small sample.
Drugs designed to halt cancer growth may offer a new way to control high blood pressure (hypertension), say Georgetown University Medical Center investigators.
In-hospital mortality rates for patients who have atrial fibrillation are significantly higher on the weekend than on weekdays, show US study results.
› Verified 7 days ago
| Entity Name | Steward Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629398219 PECOS PAC ID: 2860688728 Enrollment ID: O20101119000007 |
News Archive
The novel angiotensin receptor neprilysin inhibitor, LCZ696, demonstrated beneficial effects in heart failure patients with preserved ejection fraction (HFpEF), according to results of the PARAMOUNT (Prospective compArison of ARNI with ARB on Management Of heart failUre with preserved ejectioN fracTion) trial.
Aegis Health Group will help Inova Health System, a not-for-profit healthcare system based in northern Virginia, grow market share through its proven business development strategies. Using Aegis' program Inova's seven hospitals will begin working with local employers to better manage the health of their workforce and link hospital-sponsored programs and services with the specific health-related needs of local businesses.
A blood test yields a wealth of information crucial to a person's health. What's needed is a device that is small and inexpensive, yet capable of quickly providing a thorough analysis using a very small sample.
Drugs designed to halt cancer growth may offer a new way to control high blood pressure (hypertension), say Georgetown University Medical Center investigators.
In-hospital mortality rates for patients who have atrial fibrillation are significantly higher on the weekend than on weekdays, show US study results.
› Verified 7 days ago
| Entity Name | Steward Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629398219 PECOS PAC ID: 2860688728 Enrollment ID: O20101119000332 |
News Archive
The novel angiotensin receptor neprilysin inhibitor, LCZ696, demonstrated beneficial effects in heart failure patients with preserved ejection fraction (HFpEF), according to results of the PARAMOUNT (Prospective compArison of ARNI with ARB on Management Of heart failUre with preserved ejectioN fracTion) trial.
Aegis Health Group will help Inova Health System, a not-for-profit healthcare system based in northern Virginia, grow market share through its proven business development strategies. Using Aegis' program Inova's seven hospitals will begin working with local employers to better manage the health of their workforce and link hospital-sponsored programs and services with the specific health-related needs of local businesses.
A blood test yields a wealth of information crucial to a person's health. What's needed is a device that is small and inexpensive, yet capable of quickly providing a thorough analysis using a very small sample.
Drugs designed to halt cancer growth may offer a new way to control high blood pressure (hypertension), say Georgetown University Medical Center investigators.
In-hospital mortality rates for patients who have atrial fibrillation are significantly higher on the weekend than on weekdays, show US study results.
› Verified 7 days ago
| Entity Name | Steward St. Annes Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932411493 PECOS PAC ID: 3678760493 Enrollment ID: O20101206001124 |
News Archive
The novel angiotensin receptor neprilysin inhibitor, LCZ696, demonstrated beneficial effects in heart failure patients with preserved ejection fraction (HFpEF), according to results of the PARAMOUNT (Prospective compArison of ARNI with ARB on Management Of heart failUre with preserved ejectioN fracTion) trial.
Aegis Health Group will help Inova Health System, a not-for-profit healthcare system based in northern Virginia, grow market share through its proven business development strategies. Using Aegis' program Inova's seven hospitals will begin working with local employers to better manage the health of their workforce and link hospital-sponsored programs and services with the specific health-related needs of local businesses.
A blood test yields a wealth of information crucial to a person's health. What's needed is a device that is small and inexpensive, yet capable of quickly providing a thorough analysis using a very small sample.
Drugs designed to halt cancer growth may offer a new way to control high blood pressure (hypertension), say Georgetown University Medical Center investigators.
In-hospital mortality rates for patients who have atrial fibrillation are significantly higher on the weekend than on weekdays, show US study results.
› Verified 7 days ago
| Entity Name | New England Sinai Hospital A Steward Family Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851646087 PECOS PAC ID: 5193972123 Enrollment ID: O20130118000243 |
News Archive
The novel angiotensin receptor neprilysin inhibitor, LCZ696, demonstrated beneficial effects in heart failure patients with preserved ejection fraction (HFpEF), according to results of the PARAMOUNT (Prospective compArison of ARNI with ARB on Management Of heart failUre with preserved ejectioN fracTion) trial.
Aegis Health Group will help Inova Health System, a not-for-profit healthcare system based in northern Virginia, grow market share through its proven business development strategies. Using Aegis' program Inova's seven hospitals will begin working with local employers to better manage the health of their workforce and link hospital-sponsored programs and services with the specific health-related needs of local businesses.
A blood test yields a wealth of information crucial to a person's health. What's needed is a device that is small and inexpensive, yet capable of quickly providing a thorough analysis using a very small sample.
Drugs designed to halt cancer growth may offer a new way to control high blood pressure (hypertension), say Georgetown University Medical Center investigators.
In-hospital mortality rates for patients who have atrial fibrillation are significantly higher on the weekend than on weekdays, show US study results.
› Verified 7 days ago
| Entity Name | Brigham And Women's Physicians Organization Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033535497 PECOS PAC ID: 3870405988 Enrollment ID: O20150107001260 |
News Archive
The novel angiotensin receptor neprilysin inhibitor, LCZ696, demonstrated beneficial effects in heart failure patients with preserved ejection fraction (HFpEF), according to results of the PARAMOUNT (Prospective compArison of ARNI with ARB on Management Of heart failUre with preserved ejectioN fracTion) trial.
Aegis Health Group will help Inova Health System, a not-for-profit healthcare system based in northern Virginia, grow market share through its proven business development strategies. Using Aegis' program Inova's seven hospitals will begin working with local employers to better manage the health of their workforce and link hospital-sponsored programs and services with the specific health-related needs of local businesses.
A blood test yields a wealth of information crucial to a person's health. What's needed is a device that is small and inexpensive, yet capable of quickly providing a thorough analysis using a very small sample.
Drugs designed to halt cancer growth may offer a new way to control high blood pressure (hypertension), say Georgetown University Medical Center investigators.
In-hospital mortality rates for patients who have atrial fibrillation are significantly higher on the weekend than on weekdays, show US study results.
› Verified 7 days ago
| Entity Name | Sound Physicians Of Massachusetts Ii Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306376397 PECOS PAC ID: 9436421567 Enrollment ID: O20170823003703 |
News Archive
The novel angiotensin receptor neprilysin inhibitor, LCZ696, demonstrated beneficial effects in heart failure patients with preserved ejection fraction (HFpEF), according to results of the PARAMOUNT (Prospective compArison of ARNI with ARB on Management Of heart failUre with preserved ejectioN fracTion) trial.
Aegis Health Group will help Inova Health System, a not-for-profit healthcare system based in northern Virginia, grow market share through its proven business development strategies. Using Aegis' program Inova's seven hospitals will begin working with local employers to better manage the health of their workforce and link hospital-sponsored programs and services with the specific health-related needs of local businesses.
A blood test yields a wealth of information crucial to a person's health. What's needed is a device that is small and inexpensive, yet capable of quickly providing a thorough analysis using a very small sample.
Drugs designed to halt cancer growth may offer a new way to control high blood pressure (hypertension), say Georgetown University Medical Center investigators.
In-hospital mortality rates for patients who have atrial fibrillation are significantly higher on the weekend than on weekdays, show US study results.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alexander Turchin, MD 221 Longwood Avenue, Rfb 2, Boston, MA 02115 Ph: (617) 732-5661 | Alexander Turchin, MD 221 Longwood Avenue, Rfb 2, Boston, MA 02115 Ph: (617) 732-5661 |
News Archive
The novel angiotensin receptor neprilysin inhibitor, LCZ696, demonstrated beneficial effects in heart failure patients with preserved ejection fraction (HFpEF), according to results of the PARAMOUNT (Prospective compArison of ARNI with ARB on Management Of heart failUre with preserved ejectioN fracTion) trial.
Aegis Health Group will help Inova Health System, a not-for-profit healthcare system based in northern Virginia, grow market share through its proven business development strategies. Using Aegis' program Inova's seven hospitals will begin working with local employers to better manage the health of their workforce and link hospital-sponsored programs and services with the specific health-related needs of local businesses.
A blood test yields a wealth of information crucial to a person's health. What's needed is a device that is small and inexpensive, yet capable of quickly providing a thorough analysis using a very small sample.
Drugs designed to halt cancer growth may offer a new way to control high blood pressure (hypertension), say Georgetown University Medical Center investigators.
In-hospital mortality rates for patients who have atrial fibrillation are significantly higher on the weekend than on weekdays, show US study results.
› Verified 7 days ago
Kaitlyn My-tu Lam, MBBS Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 Phone: 617-724-7738 | |
Kui Toh Gerard Leong, M.D. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 55 Fruit Street, Massachusetts General Hospital, Boston, MA 02114 Phone: 617-726-8862 | |
Ruma Rajbhandari, Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 75 Francis St, Boston, MA 02115 Phone: 617-525-6841 | |
Alaka Ray, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 Phone: 617-726-2066 | |
Meghan E Sise, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 Phone: 617-726-2862 | |
Aaron Dickstein, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 800 Washington St, Box 233, Boston, MA 02111 Phone: 617-636-5883 Fax: 617-636-9292 | |
Dr. Felicia Elizabeth Patch, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 801 Massachusetts Ave, Crosstown 2, Boston, MA 02118 Phone: 617-414-4376 Fax: 617-414-4676 |